Drug
Fospropofol Disodium
Fospropofol Disodium: highest development phase Post-Market, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fospropofol disodium NCT01195103 | Post-Market | Procedural Sedation |
Latest
No recent events.
Follow Fospropofol Disodium on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.